Accessibility Menu
 
Ucb logo

Ucb

(OTC) UCBJY

Current Price$141.40
Market Cap$53.83B
Since IPO (2010)+900%
5 Year+219%
1 Year+47%
1 Month-16%

Ucb Financials at a Glance

Market Cap

$53.83B

Revenue (TTM)

$13.86B

Net Income (TTM)

$2.61B

EPS (TTM)

$4.59

P/E Ratio

30.17

Dividend

$0.79

Beta (Volatility)

0.45 (Low)

Price

$141.40

Volume

24,902

Open

$144.32

Previous Close

$141.40

Daily Range

$140.71 - $144.67

52-Week Range

$71.16 - $168.76

UCBJY News

No articles available.

UCBJY: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ucb

Industry

Pharmaceuticals

Employees

10,117

CEO

Jean-Christophe Tellier, MD

Headquarters

Brussels, 1070, BE

UCBJY Financials

Key Financial Metrics (TTM)

Gross Margin

74%

Operating Margin

25%

Net Income Margin

20%

Return on Equity

15%

Return on Capital

14%

Return on Assets

9%

Earnings Yield

3.31%

Dividend Yield

0.01%

Payout Ratio

16.94%

Stock Overview

Market Cap

$53.83B

Shares Outstanding

380.72M

Volume

24.90K

Short Interest

0.00%

Avg. Volume

30.55K

Financials (TTM)

Gross Profit

$5.29B

Operating Income

$1.12B

EBITDA

$1.72B

Operating Cash Flow

$2.08B

Capital Expenditure

$269.91M

Free Cash Flow

$1.81B

Cash & ST Invst.

$2.47B

Total Debt

$2.24B

Ucb Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$4.22B

+58.6%

Gross Profit

$3.04B

+83.6%

Gross Margin

71.91%

N/A

Market Cap

$53.83B

N/A

Market Cap/Employee

$5.95M

N/A

Employees

9,052

N/A

Net Income

$1.07B

+3259.3%

EBITDA

$1.59B

+194.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$224.90M

+110.6%

Accounts Receivable

$1.79B

+132.6%

Inventory

$1.50B

+45.0%

Long Term Debt

$2.18B

-27.2%

Short Term Debt

$61.97M

+47.6%

Return on Assets

8.58%

N/A

Return on Invested Capital

14.25%

N/A

Free Cash Flow

$1.38B

+344.9%

Operating Cash Flow

$1.55B

+231.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ARGNFargenx SE
$814.94+0.00%
IPSEYIpsen S.A.
$44.63+0.00%
HOCPFHOYA Corporation
$175.79+0.00%
CMXHFCSL Limited
$97.95-0.74%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%

Questions About UCBJY

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.